SEC Form 4 · accession 0001209191-16-115072
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Weiser
Director
Period of report
Apr 19, 2016
Accepted (ET)
Apr 20, 2016 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 19, 2016 | M | 15,000 | $5.01 | A | 206,548 | D | |
| Common StockF1 | Apr 19, 2016 | F | 10,751 | $8.88 | D | 195,797 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $5.01 | Apr 19, 2016 | M | 15,000 | D | Apr 26, 2006 | Apr 26, 2016 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Represents shares withheld to pay the exercise price and withholding tax obligations.